Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd (000766.SZ) plans to invest 70 million yuan to establish Guilin Jinma Innovation Investment Co., Ltd.

Tonghua Golden-Horse Pharmaceutical Industry Co, Ltd (000766.SZ) announced that, based on the company's overall strategic planning and research and development business needs, the company plans to invest 70 million yuan in the establishment of a wholly-owned subsidiary, Guilin Jinma Innovation Investment Co., Ltd, using its own or self-raised funds. The establishment of this wholly-owned subsidiary is in line with the company's strategy of transforming into an innovation-driven modern pharmaceutical enterprise, strengthening the mergers and acquisitions and layout of the innovative drug industry, enhancing the company's core competitiveness, and injecting new impetus into the company's long-term sustainable development.